In in vitro experiments, TRIM18 overexpression has been reported to strongly enhance PPM1A ubiquitination and reduce type-I IFN responses in response to viral infection, while in in vivo studies, TRIM18-deficient mice have exhibited enhanced antiviral immunity and reduced susceptibility to viral myocarditis [45]. This evidence concerns the gene MID1 and viral myocarditis.